Learn more about anticoagulants watch our video infographic

Anticoagulation UK is proud to be the winner of the Global Health and Pharma

Best Thrombosis Awareness & Support Advocacy UK - 2019

09 August 2019

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

The study concludes that in patients with a first episode of unprovoked VTE who completed at least three months of anticoagulant treatment, the risk of recurrent VTE was 10% in the first year after treatment, 16% at two years, 25% at five years, and 36% at 10 years.